B
ITOS

Bailard’s iTeos Therapeutics ITOS Stock Holding History

Bailard’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,200
Closed -$152K – 834
2025
Q2 		$152K Buy
+15,200
New +$122K ﹤0.01% 729

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bailard's ITOS Position: Q3 2025 in Review

Bailard sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 15,200 shares — an estimated $152K sold.

Bailard first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $152K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Bailard reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Bailard sold 15,200 iTeos Therapeutics shares in Q3 2025, an estimated $152K.
  • Bailard first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
  • Bailard's iTeos Therapeutics position peaked at $152K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Bailard's 13F filing for Q3 2025, filed 30 Oct 2025.